{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:51:29Z","timestamp":1792788689210,"version":"4.5.0"},"reference-count":120,"publisher":"Bentham Science Publishers Ltd.","issue":"3","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CVP"],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n<jats:title>Background::<\/jats:title>\n<jats:p>The first-line treatment for non-alcoholic fatty liver disease (NAFLD) is\nlifestyle modification; this should accompany any pharmacological intervention. Intermittent fasting\n(IF) has shown benefits over metabolic and cardiovascular parameters. Non-religious IF includes\nTime-Restricted Feeding (TRF), Alternate-Day Fasting (ADF), and 5:2 IF interventions.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective::<\/jats:title>\n<jats:p>To evaluate the effects of IF on anthropometric, liver damage, and lipid profile markers in\nsubjects with NAFLD.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods::<\/jats:title>\n<jats:p>A bibliographic search was carried out according to the Preferred Reporting Items for\nSystematic Reviews and Meta-Analyses (PRISMA) guidelines using PubMed and Scopus databases.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results::<\/jats:title>\n<jats:p>Five studies involving 470 patients with NAFLD were included. In relation to anthropometric\nmarkers, all the articles reported body weight reduction (2.48-7.63%), but only ADF and 5:2 IF\nreported a body weight reduction &gt;5%; also, all the articles reported fat mass reduction. Concerning\nhepatic markers, all the articles reported a reduction in hepatic steatosis and alanine aminotransferase\nactivity, but no changes in fat-free mass and high-density lipoprotein cholesterol levels. There were\nvariable results on fibrosis, other liver enzymes, waist circumference and body mass index, as well as\nthe levels of triglycerides, total cholesterol, and low-density lipoprotein cholesterol.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion::<\/jats:title>\n<jats:p>Any form of IF could be potentially beneficial for NAFLD treatment and some associated\ncardiometabolic parameters. However, it is necessary to evaluate the effects and safety of IF in\nlong-term studies involving a higher number of participants with different stages of NAFLD. The\neffect of IF on NAFLD-associated vascular risk also needs evaluation.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0115701611285401240110074530","type":"journal-article","created":{"date-parts":[[2024,2,4]],"date-time":"2024-02-04T20:42:36Z","timestamp":1707079356000},"page":"187-202","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Effect of Intermittent Fasting on Lipid Profile, Anthropometric and\nHepatic Markers in Non-Alcoholic Fatty Liver Disease (NAFLD): A\nSystematic Review"],"prefix":"10.2174","volume":"22","author":[{"given":"Mar\u00eda Fernanda","family":"Castillo","sequence":"first","affiliation":[{"name":"Institute of Nutrition and Food Technology, University of Chile, El L\u00edbano 5524, Macul, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Salgado-Canales","sequence":"additional","affiliation":[{"name":"Department\nof Health Sciences, Faculty of Medicine, Pontificia Universidad Cat\u00f3lica de Chile, Vicu\u00f1a Mackenna 4860, Macul Santiago,\nChile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Arrese","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, School of Medicine, Pontificia Universidad Cat\u00f3lica de Chile, Diagonal\nParaguay 362, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Barrera","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, School of Medicine, Pontificia Universidad Cat\u00f3lica de Chile, Diagonal\nParaguay 362, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri P","family":"Mikhailidis","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry, Royal Free Hospital Campus, Medical School,\nUniversity College London (UCL), Pond Street, London NW3 2QG, UK"},{"name":"Mohammed Bin Rashid University of Medicine\nand Health Sciences, Dubai, UAE"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","volume":"77","author":"Rinella M.E.","year":"2023","unstructured":"Rinella M.E.; Neuschwander-Tetri B.A.; Siddiqui M.S.; AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology  2023,77(5),1797-1835","journal-title":"Hepatology"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.mpmed.2019.08.007","volume":"47","author":"Pavlides M.","year":"2019","unstructured":"Pavlides M.; Cobbold J.; Non-alcoholic fatty liver disease. Medicine  2019,47(11),728-733","journal-title":"Medicine"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s11901-017-0378-2","volume":"16","author":"Ekstedt M.","year":"2017","unstructured":"Ekstedt M.; Nasr P.; Kechagias S.; Natural history of NAFLD\/NASH. Curr Hepatol Rep  2017,16(4),391-397","journal-title":"Curr Hepatol Rep"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"101133","DOI":"10.1016\/j.aohep.2023.101133","volume":"29","author":"Rinella M.E.","year":"2024","unstructured":"Rinella M.E.; Lazarus J.V.; Ratziu V.; A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Ann Hepatol  2024,29(1),101133","journal-title":"Ann Hepatol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","volume":"19","author":"Lazarus J.V.","year":"2022","unstructured":"Lazarus J.V.; Mark H.E.; Anstee Q.M.; Advancing the global public health agenda for NAFLD: A consensus statement. Nat Rev Gastroenterol Hepatol  2022,19(1),60-78","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","volume":"70","author":"Younossi Z.M.","year":"2019","unstructured":"Younossi Z.M.; Non-alcoholic fatty liver disease - A global public health perspective. J Hepatol  2019,70(3),531-544","journal-title":"J Hepatol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1016\/j.amjcard.2017.07.107","volume":"120","author":"Keskin M.","year":"2017","unstructured":"Keskin M.; Hay\u0131ro&#x11F;lu M.\u0130.; Uzun A.O.; G&#xFC;ven&#xE7; T.S.; &#x15E;ahin S.; Kozan &#xD6;.; Effect of nonalcoholic fatty liver disease on in-hospital and long-term outcomes in patients with st-segment elevation myocardial infarction. Am J Cardiol  2017,120(10),1720-1726","journal-title":"Am J Cardiol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/MOG.0000000000000927","volume":"39","author":"Ajmera V.","year":"2023","unstructured":"Ajmera V.; Loomba R.; Advances in the genetics of nonalcoholic fatty liver disease. Curr Opin Gastroenterol  2023,39(3),150-155","journal-title":"Curr Opin Gastroenterol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3390\/ijms17050633","volume":"17","author":"Pet&#xE4;j&#xE4; E.","year":"2016","unstructured":"Pet&#xE4;j&#xE4; E.; Yki-J&#xE4;rvinen H.; Definitions of normal liver fat and the association of insulin sensitivity with acquired and genetic NAFLD-a systematic review. Int J Mol Sci  2016,17(5),633","journal-title":"Int J Mol Sci"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1053\/j.gastro.2023.04.025","volume":"165","author":"Huang D.Q.","year":"2023","unstructured":"Huang D.Q.; Wilson L.A.; Behling C.; Fibrosis progression rate in biopsy-proven nonalcoholic fatty liver disease among people with diabetes versus people without diabetes: A multicenter study. Gastroenterology  2023,165(2),463-472.e5","journal-title":"Gastroenterology"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","volume":"77","author":"Younossi Z.M.","year":"2023","unstructured":"Younossi Z.M.; Golabi P.; Paik J.M.; Henry A.; Van Dongen C.; Henry L.; The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): A systematic review. Hepatology  2023,77(4),1335-1347","journal-title":"Hepatology"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.21037\/tgh.2019.09.08","volume":"5","author":"Mitra S.","year":"2020","unstructured":"Mitra S.; De A.; Chowdhury A.; Epidemiology of non-alcoholic and alcoholic fatty liver diseases. Transl Gastroenterol Hepatol  2020,5,16","journal-title":"Transl Gastroenterol Hepatol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"Riazi K.","year":"2022","unstructured":"Riazi K.; Azhari H.; Charette J.H.; The prevalence and incidence of NAFLD worldwide: A systematic review and meta-analysis. Lancet Gastroenterol Hepatol  2022,7(9),851-861","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.12998\/wjcc.v10.i5.1457","volume":"10","author":"Chen X.Y.","year":"2022","unstructured":"Chen X.Y.; Wang C.; Huang Y.Z.; Zhang L.L.; Nonalcoholic fatty liver disease shows significant sex dimorphism. World J Clin Cases  2022,10(5),1457-1472","journal-title":"World J Clin Cases"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.tem.2019.07.013","volume":"30","author":"El-Agroudy N.N.","year":"2019","unstructured":"El-Agroudy N.N.; Kurzbach A.; Rodionov R.N.; Are lifestyle therapies effective for NAFLD treatment? Trends Endocrinol Metab  2019,30(10),701-709","journal-title":"Trends Endocrinol Metab"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.aohep.2020.09.006","volume":"19","author":"Arab J.P.","year":"2020","unstructured":"Arab J.P.; Dirchwolf M.; &#xC1;lvares-da-Silva M.R.; Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease. Ann Hepatol  2020,19(6),674-690","journal-title":"Ann Hepatol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.metabol.2017.02.014","volume":"71","author":"Athyros V.G.","year":"2017","unstructured":"Athyros V.G.; Alexandrides T.K.; Bilianou H.; The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement. Metabolism  2017,71,17-32","journal-title":"Metabolism"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1161\/HYPERTENSIONAHA.122.17982","volume":"79","author":"Muzurovi\u0107 E.","year":"2022","unstructured":"Muzurovi\u0107 E.; Peng C.C.H.; Belanger M.J.; Sanoudou D.; Mikhailidis D.P.; Mantzoros C.S.; Nonalcoholic fatty liver disease and cardiovascular disease: A review of shared cardiometabolic risk factors. Hypertension  2022,79(7),1319-1326","journal-title":"Hypertension"},{"key":"ref=19","first-page":"72","volume":"36","author":"Puri P.","year":"2019","unstructured":"Puri P.; Fuchs M.; Population management of nonalcoholic fatty liver disease. Fed Pract  2019,36(2),72-82","journal-title":"Fed Pract"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.jhep.2017.05.016","volume":"67","author":"Romero-G&#xF3;mez M.","year":"2017","unstructured":"Romero-G&#xF3;mez M.; Zelber-Sagi S.; Trenell M.; Treatment of NAFLD with diet, physical activity and exercise. J Hepatol  2017,67(4),829-846","journal-title":"J Hepatol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12902-022-00980-1","volume":"22","author":"Pouwels S.","year":"2022","unstructured":"Pouwels S.; Sakran N.; Graham Y.; Non-alcoholic fatty liver disease (NAFLD): A review of pathophysiology, clinical management and effects of weight loss. BMC Endocr Disord  2022,22(1),63","journal-title":"BMC Endocr Disord"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1017\/S0007114523000028","volume":"130","author":"Pettinelli P.","year":"2023","unstructured":"Pettinelli P.; Fern&#xE1;ndez T.; Aguirre C.; Barrera F.; Riquelme A.; Fern&#xE1;ndez-Verdejo R.; Prevalence of non-alcoholic fatty liver disease and its association with lifestyle habits in adults in Chile: A cross-sectional study from the National Health Survey 2016-2017. Br J Nutr  2023,130(6),1036-1046","journal-title":"Br J Nutr"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jhep.2013.02.012","volume":"59","author":"Ryan M.C.","year":"2013","unstructured":"Ryan M.C.; Itsiopoulos C.; Thodis T.; The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. J Hepatol  2013,59(1),138-143","journal-title":"J Hepatol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/liv.12990","volume":"36","author":"Razavi Zade M.","year":"2016","unstructured":"Razavi Zade M.; Telkabadi M.H.; Bahmani F.; Salehi B.; Farshbaf S.; Asemi Z.; The effects of DASH diet on weight loss and metabolic status in adults with non\u2010alcoholic fatty liver disease: A randomized clinical trial. Liver Int  2016,36(4),563-571","journal-title":"Liver Int"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/nu13010015","volume":"13","author":"Ristic-Medic D.","year":"2020","unstructured":"Ristic-Medic D.; Kovacic M.; Takic M.; Calorie-restricted mediterranean and low-fat diets affect fatty acid status in individuals with nonalcoholic fatty liver disease. Nutrients  2020,13(1),15","journal-title":"Nutrients"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","volume":"149","author":"Vilar-Gomez E.","year":"2015","unstructured":"Vilar-Gomez E.; Martinez-Perez Y.; Calzadilla-Bertot L.; Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology  2015,149(2),367-378","journal-title":"Gastroenterology"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1037\/0278-6133.19.Suppl1.5","volume":"19","author":"Jeffery R.W.","year":"2000","unstructured":"Jeffery R.W.; Epstein L.H.; Wilson G.T.; Long-term maintenance of weight loss: Current status. Health Psychol  2000,19(1)(Suppl.),5-16","journal-title":"Health Psychol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"Mach F.","year":"2020","unstructured":"Mach F.; Baigent C.; Catapano A.L.; 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Eur Heart J  2020,41(1),111-188","journal-title":"Eur Heart J"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.jacl.2023.05.099","volume":"17","author":"Kirkpatrick C.F.","year":"2023","unstructured":"Kirkpatrick C.F.; Sikand G.; Petersen K.S.; Nutrition interventions for adults with dyslipidemia: A clinical perspective from the national lipid association. J Clin Lipidol  2023,17(4),428-451","journal-title":"J Clin Lipidol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1161\/CIR.0000000000001078","volume":"146","author":"Lloyd-Jones D.M.","year":"2022","unstructured":"Lloyd-Jones D.M.; Allen N.B.; Anderson C.A.M.; Life\u2019s essential 8: Updating and enhancing the American heart association\u2019s construct of cardiovascular health: A presidential advisory from the American heart association. Circulation  2022,146(5),e18-e43","journal-title":"Circulation"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s11883-022-01068-w","volume":"24","author":"Kris-Etherton P.M.","year":"2022","unstructured":"Kris-Etherton P.M.; Sapp P.A.; Riley T.M.; Davis K.M.; Hart T.; Lawler O.; The dynamic interplay of healthy lifestyle behaviors for cardiovascular health. Curr Atheroscler Rep  2022,24(12),969-980","journal-title":"Curr Atheroscler Rep"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.atherosclerosis.2020.12.020","volume":"319","author":"Tekke&#x15F;in A.\u0130.","year":"2021","unstructured":"Tekke&#x15F;in A.\u0130.; Hay\u0131ro&#x11F;lu M.\u0130.; &#xC7;inier G.; Lifestyle intervention using mobile technology and smart devices in patients with high cardiovascular risk: A pragmatic randomised clinical trial. Atherosclerosis  2021,319,21-27","journal-title":"Atherosclerosis"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.33963\/KP.a2021.0108","volume":"79","author":"Hay\u0131ro&#x11F;lu M.\u0130.","year":"2021","unstructured":"Hay\u0131ro&#x11F;lu M.\u0130.; &#xC7;\u0131nar T.; &#xC7;inier G.; The effect of 1-year mean step count on the change in the atherosclerotic cardiovascular disease risk calculation in patients with high cardiovascular risk: A sub-study of the LIGHT randomized clinical trial. Kardiol Pol  2021,79(10),1140-1142","journal-title":"Kardiol Pol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.arr.2016.10.005","volume":"39","author":"Mattson M.P.","year":"2017","unstructured":"Mattson M.P.; Longo V.D.; Harvie M.; Impact of intermittent fasting on health and disease processes. Ageing Res Rev  2017,39,46-58","journal-title":"Ageing Res Rev"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1056\/NEJMra1905136","volume":"381","author":"de Cabo R.","year":"2019","unstructured":"de Cabo R.; Mattson M.P.; Effects of intermittent fasting on health, aging, and disease. N Engl J Med  2019,381(26),2541-2551","journal-title":"N Engl J Med"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1002\/oby.22829","volume":"28","author":"Hoddy K.K.","year":"2020","unstructured":"Hoddy K.K.; Marlatt K.L.; &#xC7;etinkaya H.; Intermittent fasting and metabolic health: From religious fast to time-restricted feeding. Obesity  2020,28(S1),S29-S37","journal-title":"Obesity"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.numecd.2019.05.056","volume":"29","author":"Mirmiran P.","year":"2019","unstructured":"Mirmiran P.; Bahadoran Z.; Gaeini Z.; Moslehi N.; Azizi F.; Effects of Ramadan intermittent fasting on lipid and lipoprotein parameters: An updated meta-analysis. Nutr Metab Cardiovasc Dis  2019,29(9),906-915","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"871682","DOI":"10.3389\/fnut.2022.871682","volume":"9","author":"Gu L.","year":"2022","unstructured":"Gu L.; Fu R.; Hong J.; Ni H.; Yu K.; Lou H.; Effects of intermittent fasting in human compared to a non-intervention diet and caloric restriction: A meta-analysis of randomized controlled trials. Front Nutr  2022,9,871682","journal-title":"Front Nutr"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.cmet.2016.06.001","volume":"23","author":"Longo V.D.","year":"2016","unstructured":"Longo V.D.; Panda S.; Fasting, circadian rhythms, and time-restricted feeding in healthy lifespan. Cell Metab  2016,23(6),1048-1059","journal-title":"Cell Metab"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1080\/17461391.2016.1223173","volume":"17","author":"Tinsley G.M.","year":"2017","unstructured":"Tinsley G.M.; Forsse J.S.; Butler N.K.; Time-restricted feeding in young men performing resistance training: A randomized controlled trial. Eur J Sport Sci  2017,17(2),200-207","journal-title":"Eur J Sport Sci"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1002\/oby.21581","volume":"24","author":"Catenacci V.A.","year":"2016","unstructured":"Catenacci V.A.; Pan Z.; Ostendorf D.; A randomized pilot study comparing zero\u2010calorie alternate\u2010day fasting to daily caloric restriction in adults with obesity. Obesity  2016,24(9),1874-1883","journal-title":"Obesity"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/ajcn\/86.1.7","volume":"86","author":"Varady K.A.","year":"2007","unstructured":"Varady K.A.; Hellerstein M.K.; Alternate-day fasting and chronic disease prevention: A review of human and animal trials. Am J Clin Nutr  2007,86(1),7-13","journal-title":"Am J Clin Nutr"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/s41580-021-00377-3","volume":"22","author":"Varady K.","year":"2021","unstructured":"Varady K.; Intermittent fasting is gaining interest fast. Nat Rev Mol Cell Biol  2021,22(9),587","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"669325","DOI":"10.3389\/fnut.2021.669325","volume":"8","author":"Yang F.","year":"2021","unstructured":"Yang F.; Liu C.; Liu X.; Effect of epidemic intermittent fasting on cardiometabolic risk factors: A systematic review and meta-analysis of randomized controlled trials. Front Nutr  2021,8,669325","journal-title":"Front Nutr"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1016\/j.clnu.2020.02.022","volume":"39","author":"Scholtens E.L.","year":"2020","unstructured":"Scholtens E.L.; Krebs J.D.; Corley B.T.; Hall R.M.; Intermittent fasting 5:2 diet: What is the macronutrient and micronutrient intake and composition? Clin Nutr  2020,39(11),3354-3360","journal-title":"Clin Nutr"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1038\/s41467-019-10563-9","volume":"10","author":"Villanueva J.E.","year":"2019","unstructured":"Villanueva J.E.; Livelo C.; Trujillo A.S.; Time-restricted feeding restores muscle function in Drosophila models of obesity and circadian-rhythm disruption. Nat Commun  2019,10(1),2700","journal-title":"Nat Commun"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.physbeh.2016.08.027","volume":"167","author":"Duncan M.J.","year":"2016","unstructured":"Duncan M.J.; Smith J.T.; Narbaiza J.; Restricting feeding to the active phase in middle-aged mice attenuates adverse metabolic effects of a high-fat diet. Physiol Behav  2016,167,1-9","journal-title":"Physiol Behav"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.cmet.2012.04.019","volume":"15","author":"Hatori M.","year":"2012","unstructured":"Hatori M.; Vollmers C.; Zarrinpar A.; Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet. Cell Metab  2012,15(6),848-860","journal-title":"Cell Metab"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1146\/annurev-nutr-082018-124320","volume":"39","author":"Chaix A.","year":"2019","unstructured":"Chaix A.; Manoogian E.N.C.; Melkani G.C.; Panda S.; Time-restricted eating to prevent and manage chronic metabolic diseases. Annu Rev Nutr  2019,39(1),291-315","journal-title":"Annu Rev Nutr"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1080\/07315724.2017.1339644","volume":"36","author":"Aliasghari F.","year":"2017","unstructured":"Aliasghari F.; Izadi A.; Gargari B.P.; Ebrahimi S.; The effects of Ramadan fasting on body composition, blood pressure, glucose metabolism, and markers of inflammation in NAFLD patients: An observational trial. J Am Coll Nutr  2017,36(8),640-645","journal-title":"J Am Coll Nutr"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1159\/000081076","volume":"48","author":"Roky R.","year":"2004","unstructured":"Roky R.; Houti I.; Moussamih S.; Qotbi S.; Aadil N.; Physiological and chronobiological changes during ramadan intermittent fasting. Ann Nutr Metab  2004,48(4),296-303","journal-title":"Ann Nutr Metab"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"4655","DOI":"10.3390\/nu14214655","volume":"14","author":"Lavallee C.M.","year":"2022","unstructured":"Lavallee C.M.; Bruno A.; Ma C.; Raman M.; The role of intermittent fasting in the management of nonalcoholic fatty liver disease: A narrative review. Nutrients  2022,14(21),4655","journal-title":"Nutrients"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"Page M.J.","year":"2021","unstructured":"Page M.J.; McKenzie J.E.; Bossuyt P.M.; The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ  2021,372(71),n71","journal-title":"BMJ"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","volume":"156","author":"Eddowes P.J.","year":"2019","unstructured":"Eddowes P.J.; Sasso M.; Allison M.; Accuracy of fibroscan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease. Gastroenterology  2019,156(6),1717-1730","journal-title":"Gastroenterology"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"Higgins JPT","year":"2011","unstructured":"Higgins JPT; Altman DG; G&#xF8;tzsche PC; The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ  2011,343(oct18 2),d5928","journal-title":"BMJ"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s12876-019-1132-8","volume":"19","author":"Cai H.","year":"2019","unstructured":"Cai H.; Qin Y.L.; Shi Z.Y.; Effects of alternate-day fasting on body weight and dyslipidaemia in patients with non-alcoholic fatty liver disease: A randomised controlled trial. BMC Gastroenterol  2019,19(1),219","journal-title":"BMC Gastroenterol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"948655","DOI":"10.3389\/fnut.2022.948655","volume":"9","author":"Kord Varkaneh H","year":"2022","unstructured":"Kord Varkaneh H; Salehi sahlabadi A; G\u0103man MA; Effects of the 5:2 intermittent fasting diet on non-alcoholic fatty liver disease: A randomized controlled trial. Front Nutr  2022,9,948655","journal-title":"Front Nutr"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"111847","DOI":"10.1016\/j.nut.2022.111847","volume":"105","author":"Kord-Varkaneh H.","year":"2023","unstructured":"Kord-Varkaneh H.; Salehi-Sahlabadi A.; Tinsley G.M.; Santos H.O.; Hekmatdoost A.; Effects of time-restricted feeding (16\/8) combined with a low-sugar diet on the management of non-alcoholic fatty liver disease: A randomized controlled trial. Nutrition  2023,105,111847","journal-title":"Nutrition"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"100256","DOI":"10.1016\/j.jhepr.2021.100256","volume":"3","author":"Holmer M.","year":"2021","unstructured":"Holmer M.; Lindqvist C.; Petersson S.; Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet - a randomised controlled trial. JHEP Reports  2021,3(3),100256","journal-title":"JHEP Reports"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"11232","DOI":"10.1038\/s41598-019-47763-8","volume":"9","author":"Johari M.I.","year":"2019","unstructured":"Johari M.I.; Yusoff K.; Haron J.; A randomised controlled trial on the effectiveness and adherence of modified alternate-day calorie restriction in improving activity of non-alcoholic fatty liver disease. Sci Rep  2019,9(1),11232","journal-title":"Sci Rep"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"597","DOI":"10.4103\/2230-8210.163172","volume":"19","author":"Sanyal D.","year":"2015","unstructured":"Sanyal D.; Mukherjee P.; Raychaudhuri M.; Ghosh S.; Mukherjee S.; Chowdhury S.; Profile of liver enzymes in non-alcoholic fatty liver disease in patients with impaired glucose tolerance and newly detected untreated type 2 diabetes. Indian J Endocrinol Metab  2015,19(5),597-601","journal-title":"Indian J Endocrinol Metab"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.4254\/wjh.v13.i11.1688","volume":"13","author":"Kalas M.A.","year":"2021","unstructured":"Kalas M.A.; Chavez L.; Leon M.; Taweesedt P.T.; Surani S.; Abnormal liver enzymes: A review for clinicians. World J Hepatol  2021,13(11),1688-1698","journal-title":"World J Hepatol"},{"key":"ref=63","first-page":"197","author":"Higgins J.P.T.","year":"2011","unstructured":"Higgins J.P.T.; Green S.;  Cochrane Handbook for Systematic Reviews of Interventions Version 510  2011,197-218","journal-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 510"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41574-022-00638-x","volume":"18","author":"Varady K.A.","year":"2022","unstructured":"Varady K.A.; Cienfuegos S.; Ezpeleta M.; Gabel K.; Clinical application of intermittent fasting for weight loss: Progress and future directions. Nat Rev Endocrinol  2022,18(5),309-321","journal-title":"Nat Rev Endocrinol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1146\/annurev-nutr-071816-064634","volume":"37","author":"Patterson R.E.","year":"2017","unstructured":"Patterson R.E.; Sears D.D.; Metabolic effects of intermittent fasting. Annu Rev Nutr  2017,37(1),371-393","journal-title":"Annu Rev Nutr"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.cmet.2022.12.001","volume":"35","author":"Ezpeleta M.","year":"2023","unstructured":"Ezpeleta M.; Gabel K.; Cienfuegos S.; Effect of alternate day fasting combined with aerobic exercise on non-alcoholic fatty liver disease: A randomized controlled trial. Cell Metab  2023,35(1),56-70","journal-title":"Cell Metab"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"e14868","DOI":"10.14814\/phy2.14868","volume":"9","author":"Kotarsky C.J.","year":"2021","unstructured":"Kotarsky C.J.; Johnson N.R.; Mahoney S.J.; Time\u2010restricted eating and concurrent exercise training reduces fat mass and increases lean mass in overweight and obese adults. Physiol Rep  2021,9(10),e14868","journal-title":"Physiol Rep"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3233\/NHA-170036","volume":"4","author":"Gabel K.","year":"2018","unstructured":"Gabel K.; Hoddy K.K.; Haggerty N.; Effects of 8-hour time restricted feeding on body weight and metabolic disease risk factors in obese adults: A pilot study. Nutr Healthy Aging  2018,4(4),345-353","journal-title":"Nutr Healthy Aging"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.3390\/nu11071500","volume":"11","author":"Anton S.D.","year":"2019","unstructured":"Anton S.D.; Lee S.A.; Donahoo W.T.; The effects of time restricted feeding on overweight, older adults: A pilot study. Nutrients  2019,11(7),1500","journal-title":"Nutrients"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1002\/oby.22756","volume":"28","author":"Chow L.S.","year":"2020","unstructured":"Chow L.S.; Manoogian E.N.C.; Alvear A.; Time-restricted eating effects on body composition and metabolic measures in humans who are overweight: A feasibility study. Obesity  2020,28(5),860-869","journal-title":"Obesity"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.cmet.2020.06.018","volume":"32","author":"Cienfuegos S.","year":"2020","unstructured":"Cienfuegos S.; Gabel K.; Kalam F.; Effects of 4- and 6-h time-restricted feeding on weight and cardiometabolic health: A randomized controlled trial in adults with obesity. Cell Metab  2020,32(3),366-378.e3","journal-title":"Cell Metab"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.3390\/nu11122854","volume":"11","author":"Keszty&#xFC;s D.","year":"2019","unstructured":"Keszty&#xFC;s D.; Cermak P.; Gulich M.; Keszty&#xFC;s T.; Adherence to time-restricted feeding and impact on abdominal obesity in primary care patients: Results of a pilot study in a pre-post design. Nutrients  2019,11(12),2854","journal-title":"Nutrients"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.nutres.2019.12.001","volume":"75","author":"McAllister M.J.","year":"2020","unstructured":"McAllister M.J.; Pigg B.L.; Renteria L.I.; Waldman H.S.; Time-restricted feeding improves markers of cardiometabolic health in physically active college-age men: A 4-week randomized pre-post pilot study. Nutr Res  2020,75,32-43","journal-title":"Nutr Res"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12986-021-00613-9","volume":"18","author":"Che T.","year":"2021","unstructured":"Che T.; Yan C.; Tian D.; Zhang X.; Liu X.; Wu Z.; Time-restricted feeding improves blood glucose and insulin sensitivity in overweight patients with type 2 diabetes: A randomised controlled trial. Nutr Metab  2021,18(1),88","journal-title":"Nutr Metab"},{"key":"ref=75","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.cmet.2022.08.018","volume":"34","author":"Manoogian E.N.C.","year":"2022","unstructured":"Manoogian E.N.C.; Zadourian A.; Lo H.C.; Feasibility of time-restricted eating and impacts on cardiometabolic health in 24-h shift workers: The healthy heroes randomized control trial. Cell Metab  2022,34(10),1442-1456","journal-title":"Cell Metab"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.cmet.2019.11.004","volume":"31","author":"Wilkinson M.J.","year":"2020","unstructured":"Wilkinson M.J.; Manoogian E.N.C.; Zadourian A.; Ten-hour time-restricted eating reduces weight, blood pressure, and atherogenic lipids in patients with metabolic syndrome. Cell Metab  2020,31(1),92-104.e5","journal-title":"Cell Metab"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"100777","DOI":"10.1016\/j.xcrm.2022.100777","volume":"3","author":"He M.","year":"2022","unstructured":"He M.; Wang J.; Liang Q.; Time-restricted eating with or without low-carbohydrate diet reduces visceral fat and improves metabolic syndrome: A randomized trial. Cell Rep Med  2022,3(10),100777","journal-title":"Cell Rep Med"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1056\/NEJMoa2114833","volume":"386","author":"Liu D.","year":"2022","unstructured":"Liu D.; Huang Y.; Huang C.; Calorie restriction with or without time-restricted eating in weight loss. N Engl J Med  2022,386(16),1495-1504","journal-title":"N Engl J Med"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"113280","DOI":"10.1016\/j.physbeh.2020.113280","volume":"230","author":"Smyers M.E.","year":"2021","unstructured":"Smyers M.E.; Koch L.G.; Britton S.L.; Wagner J.G.; Novak C.M.; Enhanced weight and fat loss from long-term intermittent fasting in obesity-prone, low-fitness rats. Physiol Behav  2021,230,113280","journal-title":"Physiol Behav"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1210\/en.2015-1622","volume":"157","author":"Gotthardt J.D.","year":"2016","unstructured":"Gotthardt J.D.; Verpeut J.L.; Yeomans B.L.; Intermittent fasting promotes fat loss with lean mass retention, increased hypothalamic norepinephrine content, and increased neuropeptide Y gene expression in diet-induced obese male mice. Endocrinology  2016,157(2),679-691","journal-title":"Endocrinology"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.cmet.2018.08.004","volume":"29","author":"Chaix A.","year":"2019","unstructured":"Chaix A.; Lin T.; Le H.D.; Chang M.W.; Panda S.; Time-restricted feeding prevents obesity and metabolic syndrome in mice lacking a circadian clock. Cell Metab  2019,29(2),303-319","journal-title":"Cell Metab"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/ijo.2017.206","volume":"42","author":"Byrne N.M.","year":"2018","unstructured":"Byrne N.M.; Sainsbury A.; King N.A.; Hills A.P.; Wood R.E.; Intermittent energy restriction improves weight loss efficiency in obese men: the MATADOR study. Int J Obes  2018,42(2),129-138","journal-title":"Int J Obes"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1024\/0300-9831\/a000623","volume":"91","author":"Razavi R.","year":"2021","unstructured":"Razavi R.; Parvaresh A.; Abbasi B.; The alternate-day fasting diet is a more effective approach than a calorie restriction diet on weight loss and hs-CRP levels. Int J Vitam Nutr Res  2021,91(3-4),242-250","journal-title":"Int J Vitam Nutr Res"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1002\/oby.22518","volume":"27","author":"Ravussin E.","year":"2019","unstructured":"Ravussin E.; Beyl R.A.; Poggiogalle E.; Hsia D.S.; Peterson C.M.; Early time-restricted feeding reduces appetite and increases fat oxidation but does not affect energy expenditure in humans. Obesity  2019,27(8),1244-1254","journal-title":"Obesity"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.cgh.2018.04.043","volume":"17","author":"Siddiqui M.S.","year":"2019","unstructured":"Siddiqui M.S.; Vuppalanchi R.; Van Natta M.L.; Vibration-controlled transient elastography to assess fibrosis and steatosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol  2019,17(1),156-163.e2","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.jhep.2017.07.027","volume":"67","author":"Hagstr&#xF6;m H.","year":"2017","unstructured":"Hagstr&#xF6;m H.; Nasr P.; Ekstedt M.; Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD. J Hepatol  2017,67(6),1265-1273","journal-title":"J Hepatol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"12956","DOI":"10.3748\/wjg.v20.i36.12956","volume":"20","author":"Machado M.V.","year":"2014","unstructured":"Machado M.V.; Cortez-Pinto H.; Non-alcoholic fatty liver disease: What the clinician needs to know. World J Gastroenterol  2014,20(36),12956-12980","journal-title":"World J Gastroenterol"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"12082","DOI":"10.3748\/wjg.v20.i34.12082","volume":"20","author":"Hassan K.","year":"2014","unstructured":"Hassan K.; Bhalla V.; El Regal M.E.; A-Kader HH. Nonalcoholic fatty liver disease: A comprehensive review of a growing epidemic. World J Gastroenterol  2014,20(34),12082-12101","journal-title":"World J Gastroenterol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/liv.15116","volume":"42","author":"Mendoza Y.P.","year":"2022","unstructured":"Mendoza Y.P.; Rodrigues S.G.; Delgado M.G.; Inflammatory activity affects the accuracy of liver stiffness measurement by transient elastography but not by two\u2010dimensional shear wave elastography in non\u2010alcoholic fatty liver disease. Liver Int  2022,42(1),102-111","journal-title":"Liver Int"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"709683","DOI":"10.3389\/fnut.2021.709683","volume":"8","author":"Yin C.","year":"2021","unstructured":"Yin C.; Li Z.; Xiang Y.; Effect of intermittent fasting on non-alcoholic fatty liver disease: Systematic review and meta-analysis. Front Nutr  2021,8,709683","journal-title":"Front Nutr"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"116","DOI":"10.14348\/molcells.2021.2147","volume":"44","author":"Berger J.M.","year":"2021","unstructured":"Berger J.M.; Moon Y.A.; Increased hepatic lipogenesis elevates liver cholesterol content. Mol Cells  2021,44(2),116-125","journal-title":"Mol Cells"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/ijo.2010.171","volume":"35","author":"Harvie M.N.","year":"2011","unstructured":"Harvie M.N.; Pegington M.; Mattson M.P.; The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: A randomized trial in young overweight women. Int J Obes  2011,35(5),714-727","journal-title":"Int J Obes"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1249\/MSS.0000000000002738","volume":"53","author":"Moro T.","year":"2021","unstructured":"Moro T.; Tinsley G.; Pacelli F.Q.; Marcolin G.; Bianco A.; Paoli A.; Twelve months of time-restricted eating and resistance training improves inflammatory markers and cardiometabolic risk factors. Med Sci Sports Exerc  2021,53(12),2577-2585","journal-title":"Med Sci Sports Exerc"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1017\/S0007114519003428","volume":"123","author":"Zeb F.","year":"2020","unstructured":"Zeb F.; Wu X.; Chen L.; Effect of time-restricted feeding on metabolic risk and circadian rhythm associated with gut microbiome in healthy males. Br J Nutr  2020,123(11),1216-1226","journal-title":"Br J Nutr"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/1475-2891-12-146","volume":"12","author":"Varady K.A.","year":"2013","unstructured":"Varady K.A.; Bhutani S.; Klempel M.C.; Alternate day fasting for weight loss in normal weight and overweight subjects: A randomized controlled trial. Nutr J  2013,12(1),146","journal-title":"Nutr J"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1002\/oby.20353","volume":"21","author":"Bhutani S.","year":"2013","unstructured":"Bhutani S.; Klempel M.C.; Kroeger C.M.; Trepanowski J.F.; Varady K.A.; Alternate day fasting and endurance exercise combine to reduce body weight and favorably alter plasma lipids in obese humans. Obesity  2013,21(7),1370-1379","journal-title":"Obesity"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1002\/oby.22449","volume":"27","author":"Hutchison A.T.","year":"2019","unstructured":"Hutchison A.T.; Regmi P.; Manoogian E.N.C.; Time-restricted feeding improves glucose tolerance in men at risk for type 2 diabetes: A randomized crossover trial. Obesity  2019,27(5),724-732","journal-title":"Obesity"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"110801","DOI":"10.1016\/j.nut.2020.110801","volume":"77","author":"Meng H.","year":"2020","unstructured":"Meng H.; Zhu L.; Kord-Varkaneh H.O.; Santos H.; Tinsley G.M.; Fu P.; Effects of intermittent fasting and energy-restricted diets on lipid profile: A systematic review and meta-analysis. Nutrition  2020,77,110801","journal-title":"Nutrition"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"7561","DOI":"10.1038\/srep07561","volume":"5","author":"Varady K.A.","year":"2015","unstructured":"Varady K.A.; Dam V.T.; Klempel M.C.; Effects of weight loss via high fat vs. low fat alternate day fasting diets on free fatty acid profiles. Sci Rep  2015,5(1),7561","journal-title":"Sci Rep"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1038\/nutd.2013.14","volume":"3","author":"Klempel M.C.","year":"2013","unstructured":"Klempel M.C.; Kroeger C.M.; Norkeviciute E.; Goslawski M.; Phillips S.A.; Varady K.A.; Benefit of a low-fat over high-fat diet on vascular health during alternate day fasting. Nutr Diabetes  2013,3(5),e71","journal-title":"Nutr Diabetes"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.clnu.2011.11.011","volume":"31","author":"Kelley G.A.","year":"2012","unstructured":"Kelley G.A.; Kelley K.S.; Roberts S.; Haskell W.; Comparison of aerobic exercise, diet or both on lipids and lipoproteins in adults: A meta-analysis of randomized controlled trials. Clin Nutr  2012,31(2),156-167","journal-title":"Clin Nutr"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"102450","DOI":"10.1016\/j.ctim.2020.102450","volume":"52","author":"Zuo S.","year":"2020","unstructured":"Zuo S.; Wang G.; Han Q.; The effects of tocotrienol supplementation on lipid profile: A meta-analysis of randomized controlled trials. Complement Ther Med  2020,52,102450","journal-title":"Complement Ther Med"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12944-020-01283-x","volume":"19","author":"Medina-Urrutia A.","year":"2020","unstructured":"Medina-Urrutia A.; Lopez-Uribe A.R.; El Hafidi M.; Chia (Salvia hispanica)-supplemented diet ameliorates non-alcoholic fatty liver disease and its metabolic abnormalities in humans. Lipids Health Dis  2020,19(1),96","journal-title":"Lipids Health Dis"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1016\/j.jacc.2012.09.017","volume":"60","author":"Ference B.A.","year":"2012","unstructured":"Ference B.A.; Yoo W.; Alesh I.; Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: A Mendelian randomization analysis. J Am Coll Cardiol  2012,60(25),2631-2639","journal-title":"J Am Coll Cardiol"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.clnesp.2018.01.002","volume":"24","author":"Santos H.O.","year":"2018","unstructured":"Santos H.O.; Macedo R.C.O.; Impact of intermittent fasting on the lipid profile: Assessment associated with diet and weight loss. Clin Nutr ESPEN  2018,24,14-21","journal-title":"Clin Nutr ESPEN"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/s12967-016-1044-0","volume":"14","author":"Moro T.","year":"2016","unstructured":"Moro T.; Tinsley G.; Bianco A.; Effects of eight weeks of time-restricted feeding (16\/8) on basal metabolism, maximal strength, body composition, inflammation, and cardiovascular risk factors in resistance-trained males. J Transl Med  2016,14(1),290","journal-title":"J Transl Med"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41574-021-00471-8","volume":"17","author":"Morigny P.","year":"2021","unstructured":"Morigny P.; Boucher J.; Arner P.; Langin D.; Lipid and glucose metabolism in white adipocytes: Pathways, dysfunction and therapeutics. Nat Rev Endocrinol  2021,17(5),276-295","journal-title":"Nat Rev Endocrinol"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/oby.22065","volume":"26","author":"Anton S.D.","year":"2018","unstructured":"Anton S.D.; Moehl K.; Donahoo W.T.; Flipping the metabolic switch: Understanding and applying the health benefits of fasting. Obesity  2018,26(2),254-268","journal-title":"Obesity"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"946474","DOI":"10.3389\/fphys.2022.946474","volume":"13","author":"Mooli R.G.R.","year":"2022","unstructured":"Mooli R.G.R.; Ramakrishnan S.K.; Emerging role of hepatic ketogenesis in fatty liver disease. Front Physiol  2022,13,946474","journal-title":"Front Physiol"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"e13627","DOI":"10.1111\/eci.13627","volume":"51","author":"Post A.","year":"2021","unstructured":"Post A.; Garcia E.; van den Berg E.H.; Nonalcoholic fatty liver disease, circulating ketone bodies and all\u2010cause mortality in a general population\u2010based cohort. Eur J Clin Invest  2021,51(12),e13627","journal-title":"Eur J Clin Invest"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.3390\/ijms24043534","volume":"24","author":"Manolis A.S.","year":"2023","unstructured":"Manolis A.S.; Manolis T.A.; Manolis A.A.; Ketone bodies and cardiovascular disease: An alternate fuel source to the rescue. Int J Mol Sci  2023,24(4),3534","journal-title":"Int J Mol Sci"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.jacc.2020.12.065","volume":"77","author":"Yurista S.R.","year":"2021","unstructured":"Yurista S.R.; Chong C.R.; Badimon J.J.; Kelly D.P.; de Boer R.A.; Westenbrink B.D.; Therapeutic potential of ketone bodies for patients with cardiovascular disease: JACC state-of-the-art review. J Am Coll Cardiol  2021,77(13),1660-1669","journal-title":"J Am Coll Cardiol"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"165739","DOI":"10.1016\/j.bbadis.2020.165739","volume":"1866","author":"Abdul Kadir A.","year":"2020","unstructured":"Abdul Kadir A.; Clarke K.; Evans R.D.; Cardiac ketone body metabolism. Biochim Biophys Acta Mol Basis Dis  2020,1866(6),165739","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.5005\/jp-journals-10018-1370","volume":"12","author":"Al Mahtab M.","year":"2022","unstructured":"Al Mahtab M.; Ghosh J.; Bhatia S.; Gender differences in nonalcoholic fatty liver disease. Euroasian J Hepatogastroenterol  2022,12(S1),S19-S25","journal-title":"Euroasian J Hepatogastroenterol"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1139\/apnm-2018-0635","volume":"44","author":"Beaudry K.M.","year":"2019","unstructured":"Beaudry K.M.; Devries M.C.; Sex-based differences in hepatic and skeletal muscle triglyceride storage and metabolism. Appl Physiol Nutr Metab  2019,44(8),805-813","journal-title":"Appl Physiol Nutr Metab"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.numecd.2016.10.004","volume":"27","author":"Du T.","year":"2017","unstructured":"Du T.; Sun X.; Yuan G.; Sex differences in the impact of nonalcoholic fatty liver disease on cardiovascular risk factors. Nutr Metab Cardiovasc Dis  2017,27(1),63-69","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S1665-2681(19)31502-9","volume":"11","author":"Florentino G.","year":"2012","unstructured":"Florentino G.; Cotrim H.P.; Florentino A.; Hormone replacement therapy in menopausal women: Risk factor or protection to nonalcoholic fatty liver disease? Ann Hepatol  2012,11(1),147-149","journal-title":"Ann Hepatol"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1590\/S0004-28032013000200032","volume":"50","author":"Florentino G.S.A.","year":"2013","unstructured":"Florentino G.S.A.; Cotrim H.P.; Vilar C.P.; Florentino A.V.A.; Guimar&#xE3;es G.M.A.; Barreto V.S.T.; Nonalcoholic fatty liver disease in menopausal women. Arq Gastroenterol  2013,50(3),180-185","journal-title":"Arq Gastroenterol"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1001\/jama.2018.20579","volume":"321","author":"Schwimmer J.B.","year":"2019","unstructured":"Schwimmer J.B.; Ugalde-Nicalo P.; Welsh J.A.; Effect of a low free sugar diet vs usual diet on nonalcoholic fatty liver disease in adolescent boys: A randomized clinical trial. JAMA  2019,321(3),256-265","journal-title":"JAMA"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"e13659","DOI":"10.1111\/eci.13659","volume":"52","author":"Pugliese N.","year":"2022","unstructured":"Pugliese N.; Plaz Torres M.C.; Petta S.; Valenti L.; Giannini E.G.; Aghemo A.; Is there an \u2018ideal\u2019 diet for patients with NAFLD? Eur J Clin Invest  2022,52(3),e13659","journal-title":"Eur J Clin Invest"}],"container-title":["Current Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115701611285401240110074530","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/225821\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115701611285401240110074530","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T12:46:59Z","timestamp":1721393219000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/225821\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":120,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115701611285401240110074530","relation":{},"ISSN":["1570-1611"],"issn-type":[{"value":"1570-1611","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-11-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-12","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}